ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Scheme : NHMRC Project Grants
Research Topic : MRNA
Clear All
Filter by Field of Research
Gene Expression (8)
Medical and Health Sciences (5)
Biochemistry And Cell Biology Not Elsewhere Classified (2)
Biochemistry and Cell Biology (2)
Central Nervous System (2)
Endocrinology (2)
Reproduction (2)
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (1)
Autoimmunity (1)
Biochemistry and Cell Biology not elsewhere classified (1)
Cell Metabolism (1)
Cellular Immunology (1)
Gene Expression (incl. Microarray and other genome-wide approaches) (1)
Medical Biochemistry: Nucleic Acids (1)
Medical Genetics (1)
Medical infection agents (incl. prions) (1)
Psychiatry (1)
Radiotherapy And Nuclear Medicine (1)
Respiratory Diseases (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (46)
Filter by Status
Closed (46)
Filter by Scheme
NHMRC Project Grants (46)
Filter by Country
Australia (2)
Filter by Australian State/Territory
VIC (2)
  • Researchers (0)
  • Funded Activities (46)
  • Organisations (0)
  • Funded Activity

    Regulation Of The Plasminogen Activator Inhibitor Type 2 Gene

    Funder
    National Health and Medical Research Council
    Funding Amount
    $281,331.00
    More information
    Funded Activity

    Molecular Control Of Fibrinolysis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $392,815.00
    More information
    Funded Activity

    Drug Metabolising Enzymes And Liver Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $287,831.00
    More information
    Funded Activity

    Neurochemical Analysis Of Brain Of Lean, Obese, And Dia Betic Mouse Brain

    Funder
    National Health and Medical Research Council
    Funding Amount
    $149,624.00
    More information
    Funded Activity

    MRNA Surveillance In Human Disease: Molecular Determinants Of Nonsense-mediated MRNA Decay

    Funder
    National Health and Medical Research Council
    Funding Amount
    $474,517.00
    Summary
    Inherited diseases are a common cause of human disability, illness and suffering. It has been estimated that 5-10% of the population will be affected by disorders with a genetic component. Thus studies on mechanisms of inherited diseases, especially those relating to genetic mechanisms with relevance across a wide range of individual disorders and gene mutations, are of great significance in diagnosis, molecular pathology and the eventual development of therapeutics. While there are many types o .... Inherited diseases are a common cause of human disability, illness and suffering. It has been estimated that 5-10% of the population will be affected by disorders with a genetic component. Thus studies on mechanisms of inherited diseases, especially those relating to genetic mechanisms with relevance across a wide range of individual disorders and gene mutations, are of great significance in diagnosis, molecular pathology and the eventual development of therapeutics. While there are many types of mutations, one relatively common type is called a premature termination mutation. Premature termination mutations introduce an inappropriate genetic signal that tells the cells to stop the formation of proteins before they are complete. This would result in the production of a protein that is shorter than normal, and these short proteins could be quite abnormal and drastically affect the normal function of cells. To overcome this, cells have developed elegant strategies that involve the deployment of quality control, or surveillance, mechanisms to remove the mutant gene product before it can be converted into an abnormal protein. This process is called nonsense mediated decay. Nonsense mediated decay is a complex process and some of the key components have been identified by studies on a small number of genes. However, our studies have identified several previously unknown aspects of the process that suggest that the currently held view of how nonsense mediated decay works is only the beginning of the story and further important complexity exists. The proposed research will explore the basic mechanisms of the surveillance process and determine the signals that initiate nonsense mediated decay. Since premature termination mutations cause one-third of all inherited genetic disorders, our studies will provide new insights into the surveillance mechanisms and will have wide applicability to our understanding of the basis of inherited disease.
    Read more Read less
    More information
    Funded Activity

    Self-regulation Of Nerve Survival

    Funder
    National Health and Medical Research Council
    Funding Amount
    $133,147.00
    More information
    Funded Activity

    A Brain System That Controls Blood Pressure

    Funder
    National Health and Medical Research Council
    Funding Amount
    $151,163.00
    More information
    Funded Activity

    The Function Of Actin Isoforms And Their MRNAs In Neuro Nal Development

    Funder
    National Health and Medical Research Council
    Funding Amount
    $276,561.00
    More information
    Funded Activity

    Which Cells Make Nerve Growth Factor?

    Funder
    National Health and Medical Research Council
    Funding Amount
    $207,376.00
    More information
    Funded Activity

    Alternative Splicing Of GLI1 And Its Role In Tumourigenesis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $392,640.00
    Summary
    Gene expression involves the transfer of information from DNA to proteins and is mediated by a third molecule called messenger RNA (mRNA). The process is tightly controlled since unregulated gene expression is harmful and can result in diseases such as developmental disorders and cancer. The genetic information in DNA is first copied to an RNA molecule in a process called transcription. This RNA molecule then undergoes a series of maturation steps before the information it carries can be transla .... Gene expression involves the transfer of information from DNA to proteins and is mediated by a third molecule called messenger RNA (mRNA). The process is tightly controlled since unregulated gene expression is harmful and can result in diseases such as developmental disorders and cancer. The genetic information in DNA is first copied to an RNA molecule in a process called transcription. This RNA molecule then undergoes a series of maturation steps before the information it carries can be translated into a protein. One of these maturation steps involves the removal of sequences (called introns) that do not contain protein coding information from the sequences (called exons) that will be present in the mature mRNA. Some genes contain no introns while others contain 20 or more, which are dispersed throughout the gene. The removal of intron sequences from immature RNA molecules is called splicing and is carried out by a macromolecular complex that recognises the intron sequences, cuts them out of the RNA and then rejoins the RNA to make a contiguous sequence. This process has to be precise otherwise spurious sequences will be present in the mRNA, which will result in the production of abnormal proteins. In addition, for some genes mRNAs are produced that have differences in a portion of their sequence. These alternative sequences are generated by the inclusion or exclusion of alternative exons. Because, RNA splicing is critical to the production of mature mRNAs and because it can generate sequence diversity it is tightly regulated. We have recently found that expression of a cancer gene (called GLI1) is regulated in part by the use of alternative GLI1 mRNAs. Moreover, we found that the expression of one of these alternative GLI1 mRNAs is associated with skin cancer. In this project we will investigate the molecular mechanisms that regulate alternative splicing in GLI1 and identify whether changes in these mechanisms result in cancer.
    Read more Read less
    More information

    Showing 1-10 of 46 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback